Efficacy of a Single Intravenous Dose of Amphotericin B in Urinary Tract Infections Caused by Candida

Studies in experimental animals and humans have demonstrated that amphotericin B (AmB) may be detectable in urine for several days to weeks following a single iv dose. Moreover, for prolonged periods, urine levels of AmB exceed the MIC reported for prolonged periods, urine levels of AmB exceed the M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 1987-10, Vol.156 (4), p.685-685
Hauptverfasser: Fisher, John F., Hicks, Biram C., Dipiro, Joseph T., Venable, Josef, Fincher, Ruth-Marie E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 685
container_issue 4
container_start_page 685
container_title The Journal of infectious diseases
container_volume 156
creator Fisher, John F.
Hicks, Biram C.
Dipiro, Joseph T.
Venable, Josef
Fincher, Ruth-Marie E.
description Studies in experimental animals and humans have demonstrated that amphotericin B (AmB) may be detectable in urine for several days to weeks following a single iv dose. Moreover, for prolonged periods, urine levels of AmB exceed the MIC reported for prolonged periods, urine levels of AmB exceed the MIC reported for many species of Candida . These findings suggest that the slow renal excretion of AmB could be advantageously used to treat urinary tract infections caused by Candida , irrespective of their location in the urinary tract. To test this hypothesis, the authors have begun a study using a single therapeutic dose of AmB in patients with persistent candiduria. They report here their preliminary data.
doi_str_mv 10.1093/infdis/156.4.685
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_77665893</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30136577</jstor_id><sourcerecordid>30136577</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-98cd410f5fafdf84ffef4a06d9fd5967446bcdc785df3c36a20bd3ac394a85c83</originalsourceid><addsrcrecordid>eNqFkb1vUzEUxS0EKmlgZ0HygNhear_rz7GEllRqxUArVSyW4w9wSfxS-wWR_x5HCe3Icn2lc85Puj4IvaNkRomGs5SjT_WMcjFjM6H4CzShHGQnBIWXaEJI33dUaf0andb6QAhhIOQJOgHRM03JBIWLGJOzboeHiC3-lvKPVcBXeSz2d8jDtuLPQw178Xy9-TmMoSSXMv6E27grKduyw7fFurFlYnBjGnLFc7utwePlrm3ZJ2_foFfRrmp4e3yn6O7y4na-6K6_frman193DpQaO62cZ5REHm30UbEYQ2SWCK-j51pIxsTSeScV9xEcCNuTpQfrQDOruFMwRR8P3E0ZHrehjmadqgurlc2h3WKkFIIrDf81UqZ6CbAnkoPRlaHWEqLZlLRuVxtKzL4Cc6jAtAoMM62CFnl_ZG-X6-CfAsc_b_qHo26rs6tYbHYN8M8mJfSKqWfMQx2H8kwhFARvpinqDnqqY_jzpNvyywgJkpvF_XezkDcc9PzG3MNfjyupVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14827338</pqid></control><display><type>article</type><title>Efficacy of a Single Intravenous Dose of Amphotericin B in Urinary Tract Infections Caused by Candida</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><creator>Fisher, John F. ; Hicks, Biram C. ; Dipiro, Joseph T. ; Venable, Josef ; Fincher, Ruth-Marie E.</creator><creatorcontrib>Fisher, John F. ; Hicks, Biram C. ; Dipiro, Joseph T. ; Venable, Josef ; Fincher, Ruth-Marie E.</creatorcontrib><description>Studies in experimental animals and humans have demonstrated that amphotericin B (AmB) may be detectable in urine for several days to weeks following a single iv dose. Moreover, for prolonged periods, urine levels of AmB exceed the MIC reported for prolonged periods, urine levels of AmB exceed the MIC reported for many species of Candida . These findings suggest that the slow renal excretion of AmB could be advantageously used to treat urinary tract infections caused by Candida , irrespective of their location in the urinary tract. To test this hypothesis, the authors have begun a study using a single therapeutic dose of AmB in patients with persistent candiduria. They report here their preliminary data.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/156.4.685</identifier><identifier>PMID: 3624910</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University Chicago Press</publisher><subject>Amphotericin B - therapeutic use ; Antibiotics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal agents ; Biological and medical sciences ; Candida ; Candidiasis - drug therapy ; Correspondence ; Diabetes mellitus ; Dosage ; Excretion ; Humans ; Infections ; Medical sciences ; Medical treatment ; Pharmacology. Drug treatments ; Urinary bladder ; Urinary tract ; Urinary tract infections ; Urinary Tract Infections - drug therapy ; Urine</subject><ispartof>The Journal of infectious diseases, 1987-10, Vol.156 (4), p.685-685</ispartof><rights>Copyright 1987 The University of Chicago</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-98cd410f5fafdf84ffef4a06d9fd5967446bcdc785df3c36a20bd3ac394a85c83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30136577$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30136577$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7732848$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3624910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fisher, John F.</creatorcontrib><creatorcontrib>Hicks, Biram C.</creatorcontrib><creatorcontrib>Dipiro, Joseph T.</creatorcontrib><creatorcontrib>Venable, Josef</creatorcontrib><creatorcontrib>Fincher, Ruth-Marie E.</creatorcontrib><title>Efficacy of a Single Intravenous Dose of Amphotericin B in Urinary Tract Infections Caused by Candida</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Studies in experimental animals and humans have demonstrated that amphotericin B (AmB) may be detectable in urine for several days to weeks following a single iv dose. Moreover, for prolonged periods, urine levels of AmB exceed the MIC reported for prolonged periods, urine levels of AmB exceed the MIC reported for many species of Candida . These findings suggest that the slow renal excretion of AmB could be advantageously used to treat urinary tract infections caused by Candida , irrespective of their location in the urinary tract. To test this hypothesis, the authors have begun a study using a single therapeutic dose of AmB in patients with persistent candiduria. They report here their preliminary data.</description><subject>Amphotericin B - therapeutic use</subject><subject>Antibiotics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal agents</subject><subject>Biological and medical sciences</subject><subject>Candida</subject><subject>Candidiasis - drug therapy</subject><subject>Correspondence</subject><subject>Diabetes mellitus</subject><subject>Dosage</subject><subject>Excretion</subject><subject>Humans</subject><subject>Infections</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Pharmacology. Drug treatments</subject><subject>Urinary bladder</subject><subject>Urinary tract</subject><subject>Urinary tract infections</subject><subject>Urinary Tract Infections - drug therapy</subject><subject>Urine</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkb1vUzEUxS0EKmlgZ0HygNhear_rz7GEllRqxUArVSyW4w9wSfxS-wWR_x5HCe3Icn2lc85Puj4IvaNkRomGs5SjT_WMcjFjM6H4CzShHGQnBIWXaEJI33dUaf0andb6QAhhIOQJOgHRM03JBIWLGJOzboeHiC3-lvKPVcBXeSz2d8jDtuLPQw178Xy9-TmMoSSXMv6E27grKduyw7fFurFlYnBjGnLFc7utwePlrm3ZJ2_foFfRrmp4e3yn6O7y4na-6K6_frman193DpQaO62cZ5REHm30UbEYQ2SWCK-j51pIxsTSeScV9xEcCNuTpQfrQDOruFMwRR8P3E0ZHrehjmadqgurlc2h3WKkFIIrDf81UqZ6CbAnkoPRlaHWEqLZlLRuVxtKzL4Cc6jAtAoMM62CFnl_ZG-X6-CfAsc_b_qHo26rs6tYbHYN8M8mJfSKqWfMQx2H8kwhFARvpinqDnqqY_jzpNvyywgJkpvF_XezkDcc9PzG3MNfjyupVg</recordid><startdate>19871001</startdate><enddate>19871001</enddate><creator>Fisher, John F.</creator><creator>Hicks, Biram C.</creator><creator>Dipiro, Joseph T.</creator><creator>Venable, Josef</creator><creator>Fincher, Ruth-Marie E.</creator><general>The University Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>19871001</creationdate><title>Efficacy of a Single Intravenous Dose of Amphotericin B in Urinary Tract Infections Caused by Candida</title><author>Fisher, John F. ; Hicks, Biram C. ; Dipiro, Joseph T. ; Venable, Josef ; Fincher, Ruth-Marie E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-98cd410f5fafdf84ffef4a06d9fd5967446bcdc785df3c36a20bd3ac394a85c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Amphotericin B - therapeutic use</topic><topic>Antibiotics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal agents</topic><topic>Biological and medical sciences</topic><topic>Candida</topic><topic>Candidiasis - drug therapy</topic><topic>Correspondence</topic><topic>Diabetes mellitus</topic><topic>Dosage</topic><topic>Excretion</topic><topic>Humans</topic><topic>Infections</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Pharmacology. Drug treatments</topic><topic>Urinary bladder</topic><topic>Urinary tract</topic><topic>Urinary tract infections</topic><topic>Urinary Tract Infections - drug therapy</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fisher, John F.</creatorcontrib><creatorcontrib>Hicks, Biram C.</creatorcontrib><creatorcontrib>Dipiro, Joseph T.</creatorcontrib><creatorcontrib>Venable, Josef</creatorcontrib><creatorcontrib>Fincher, Ruth-Marie E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fisher, John F.</au><au>Hicks, Biram C.</au><au>Dipiro, Joseph T.</au><au>Venable, Josef</au><au>Fincher, Ruth-Marie E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of a Single Intravenous Dose of Amphotericin B in Urinary Tract Infections Caused by Candida</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1987-10-01</date><risdate>1987</risdate><volume>156</volume><issue>4</issue><spage>685</spage><epage>685</epage><pages>685-685</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>Studies in experimental animals and humans have demonstrated that amphotericin B (AmB) may be detectable in urine for several days to weeks following a single iv dose. Moreover, for prolonged periods, urine levels of AmB exceed the MIC reported for prolonged periods, urine levels of AmB exceed the MIC reported for many species of Candida . These findings suggest that the slow renal excretion of AmB could be advantageously used to treat urinary tract infections caused by Candida , irrespective of their location in the urinary tract. To test this hypothesis, the authors have begun a study using a single therapeutic dose of AmB in patients with persistent candiduria. They report here their preliminary data.</abstract><cop>Chicago, IL</cop><pub>The University Chicago Press</pub><pmid>3624910</pmid><doi>10.1093/infdis/156.4.685</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1987-10, Vol.156 (4), p.685-685
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_77665893
source Jstor Complete Legacy; MEDLINE
subjects Amphotericin B - therapeutic use
Antibiotics
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal agents
Biological and medical sciences
Candida
Candidiasis - drug therapy
Correspondence
Diabetes mellitus
Dosage
Excretion
Humans
Infections
Medical sciences
Medical treatment
Pharmacology. Drug treatments
Urinary bladder
Urinary tract
Urinary tract infections
Urinary Tract Infections - drug therapy
Urine
title Efficacy of a Single Intravenous Dose of Amphotericin B in Urinary Tract Infections Caused by Candida
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T20%3A54%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20a%20Single%20Intravenous%20Dose%20of%20Amphotericin%20B%20in%20Urinary%20Tract%20Infections%20Caused%20by%20Candida&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Fisher,%20John%20F.&rft.date=1987-10-01&rft.volume=156&rft.issue=4&rft.spage=685&rft.epage=685&rft.pages=685-685&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/156.4.685&rft_dat=%3Cjstor_proqu%3E30136577%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14827338&rft_id=info:pmid/3624910&rft_jstor_id=30136577&rfr_iscdi=true